Patent · US Active

Antibodies specific to folate receptor alpha

US12378310B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignee

Multitude Inc. · CN

Inventors

Bing Hou · Shanghai, CN
Na Wang · San Jose, US
Xun Meng · Shanghai, CN

Key dates

Filing date	Jan 8, 2021
Grant date	Aug 5, 2025
Priority date	—
Expiry date	Dec 12, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/33
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies specific to folate receptor alpha (a.k.a. folate receptor 1 or FOLR1) and uses thereof for therapeutic and diagnostic purposes. Also provided herein are chimeric antigen receptors (CARs) comprising an extracellular antigen-binding fragment that binds FOLR1 and immune cells expressing such.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.